SVB Leerink Maintains Outperform on DexCom, Raises Price Target to $500
SVB Leerink analyst Danielle Antalffy maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $485 to $500.
12 Stocks Moving In Thursday’s After-Hours Session
Gainers
Atlassian (NASDAQ: TEAM) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance above estimates.
Why DexCom’s Stock Is Trading Higher Today
DexCom, Inc. (NASDAQ: DXCM) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued FY21 sales guidance above estimates.
Recap: DexCom Q2 Earnings
Shares of DexCom (NASDAQ:DXCM) rose 3.7% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 3.80% year over year to $0.76, which beat the estimate of $0.45.
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
DexCom Says FDA Clears Co’s Real-Time APIs For Third-Party Apps And Devices
Clearance expands connectivity and interoperability of the Dexcom CGM digital ecosystem
Allows invited third-party developers to connect applications and devices to real-time CGM data
Gives Dexcom users more choice
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ:
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Study results from a glucose monitoring company were reported after market close Thursday.